Prostate Cancer

Zoledronic Acid Benefits Confirmed

STOCKHOLM—Treatment with zoledronic acid for two years in men who are undergoing androgen deprivation therapy (ADT) for prostate cancer is usually well tolerated and effective for preventing bone loss, new findings suggest.

Next post in Prostate Cancer